T Kanesaka1, M Mori, T Hattori, T Oki, S Kuwabara. 1. Department of Neurology, Chiba University School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670 Japan. kane2000@f7.dion.ne.jp
Abstract
BACKGROUND: Adhesion molecules and matrix metalloproteinases (MMPs) are known to be relevant to the ongoing development and disappearance of areas of demyelination in the white matter of the CNS of multiple sclerosis (MS) patients. This study examined whether serum matrix metalloproteinase-3 (MMP-3) levels correlate with disease activity in MS. METHODS: Serum MMP-3 levels in 47 consecutive patients with relapsing-remitting MS were measured by immunoassay every 4 weeks over a 15 month period. RESULTS: During the study period, 48 clinical relapses occurred. Serum MMP-3 levels within 1 month of relapse were significantly higher than during the remission phase. Sequential analysis showed that serum MMP-3 levels had increased transiently at the time of clinical relapse but returned to the normal range within a month. CONCLUSIONS: Circulatory MMP-3 levels are correlated with disease activity in relapsing-remitting MS. This may contribute to the breakdown of the blood-brain barrier at the time of relapse.
BACKGROUND: Adhesion molecules and matrix metalloproteinases (MMPs) are known to be relevant to the ongoing development and disappearance of areas of demyelination in the white matter of the CNS of multiple sclerosis (MS) patients. This study examined whether serum matrix metalloproteinase-3 (MMP-3) levels correlate with disease activity in MS. METHODS: Serum MMP-3 levels in 47 consecutive patients with relapsing-remitting MS were measured by immunoassay every 4 weeks over a 15 month period. RESULTS: During the study period, 48 clinical relapses occurred. Serum MMP-3 levels within 1 month of relapse were significantly higher than during the remission phase. Sequential analysis showed that serum MMP-3 levels had increased transiently at the time of clinical relapse but returned to the normal range within a month. CONCLUSIONS: Circulatory MMP-3 levels are correlated with disease activity in relapsing-remitting MS. This may contribute to the breakdown of the blood-brain barrier at the time of relapse.
Authors: E Waubant; D E Goodkin; L Gee; P Bacchetti; R Sloan; T Stewart; P B Andersson; G Stabler; K Miller Journal: Neurology Date: 1999-10-22 Impact factor: 9.910
Authors: J A Cossins; J M Clements; J Ford; K M Miller; R Pigott; W Vos; P Van der Valk; C J De Groot Journal: Acta Neuropathol Date: 1997-12 Impact factor: 17.088
Authors: Elizabeth Milward; Kee Jun Kim; Arek Szklarczyk; Thien Nguyen; Giorgia Melli; Mamatha Nayak; Deepa Deshpande; Chantel Fitzsimmons; Ahmet Hoke; Douglas Kerr; John W Griffin; Peter A Calabresi; Katherine Conant Journal: J Neuroimmunol Date: 2007-12-11 Impact factor: 3.478
Authors: Srdjan Ljubisavljevic; I Stojanovic; J Basic; S Vojinovic; D Stojanov; G Djordjevic; D Pavlovic Journal: J Mol Neurosci Date: 2015-02-22 Impact factor: 3.444
Authors: Marc Pawlitzki; Julia Uebelhör; Catherine M Sweeney-Reed; Heike Stephanik; Juliane Hoffmann; Anke Lux; Dirk Reinhold Journal: Nutrients Date: 2018-07-26 Impact factor: 5.717